Palisade Bio (PALI) Return on Sales Growth (5y) (2016 - 2023)
Palisade Bio (PALI) Return on Sales Growth (5y) (2016 - 2023) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 519.00 |
| Sep 30, 2023 | 629.00 |
| Jun 30, 2023 | -193.00 |
| Mar 31, 2023 | 817.00 |
| Sep 30, 2022 | -6,343.00 |
| Jun 30, 2022 | -1,598.00 |
| Mar 31, 2022 | -4,482.00 |
| Dec 31, 2020 | 604.00 |
| Sep 30, 2020 | 1,517.00 |
| Jun 30, 2020 | 1,420.00 |
| Mar 31, 2020 | 1,331.00 |
| Dec 31, 2019 | 330.00 |
| Sep 30, 2019 | 24.00 |
| Jun 30, 2019 | 1,106.00 |
| Mar 31, 2019 | 430.00 |
| Dec 31, 2018 | 607.00 |
| Sep 30, 2018 | 1,846.00 |
| Jun 30, 2018 | 2,493.00 |
| Mar 31, 2018 | -935.00 |
| Dec 31, 2017 | 1,077.00 |